Purpose
To explore the degree to which OpenBind's fragment-based drug-discovery approach can be impactful in high-priority program areas (TB, malaria and non-hormonal contraceptives) and can be generalized to new molecular targets of interest.
Grantee
Division
Global Health
Date
JUNE 2026
Region served
GLOBAL
Committed amount
$2,872,749
Grant topic
Create Novel Technology Platform Capabilities,
Discovery and Translational Sciences
Duration (months)
18
Grantee location
Didcot, Oxfordshire, United Kingdom
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.